Treating Multiple Sclerosis: Are They Doing It Wrong?
@AaronBosterMD Click red box to activate this video…
PRESS RELEASE : Tolebrutinib designated Breakthrough Therapy by the FDA for non-relapsing secondary progressive multiple sclerosis
Paris, December 13, 2024. The US Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to tolebrutinib for the treatment of…
Stuart Schlossman
Gabapentinoids, yet another dirty secret
Some people with MS are on ten or more concomitant medications including gabapentin or pregabalin. Are you? Gavin Giovannoni –…
Stuart Schlossman
Let’s Move From Categorizing MS by Clinical Phenotype to Underlying Disease Mechanisms
September 19, 2024 – Meaningful characterization is critical to advancing research and care, review authors contend The currently used phenotypic…
Stuart Schlossman
New Novartis data in relapsing MS reinforce benefits of Kesimpta® for first-line and switch patients
Sep 18, 2024 East Hanover, September 18, 2024 – Novartis today announced new data from the ALITHIOS open-label extension study. Data…
Stuart Schlossman
Press Release: FDA Approves Ocrevus Zunovo™ as the First and Only Twice-a-Year 10-Minute Subcutaneous Injection for People With Relapsing and Progressive Multiple Sclerosis
Ocrevus Zunovo™ has the potential to expand treatment options to centers without IV infrastructure or with IV constraints, like at a…
Stuart Schlossman
Press Release: Tolebrutinib meets primary endpoint in HERCULES phase 3 study, the first and only to show reduction in disability accumulation in non-relapsing secondary progressive multiple sclerosis
September 2, 2024 • In the HERCULES study, tolebrutinib met the primary endpoint in delaying time to onset of confirmed…
Stuart Schlossman
Why BOTHER taking MS Medications?
No excerpt…
Stuart Schlossman
“MS101, The Basics” with Aaron Boster, MD
At the 2024 MS WELLNESS SUMMIT, Doctor Aaron Boster, MD an MS Neurologist, discusses his 6-for-6 for YOUR care in…
Stuart Schlossman
Prescription Assistance
If you need help paying for your medication, our guide can help you find the right assistance. This guide was…
Stuart Schlossman
